1. 2023
  2. Characteristics of severe asthma patients on biologics: a real-life European registry study

    Principe, S., Richards, L. B., Hashimoto, S., Kroes, J. A., Van Bragt, J. J. M. H., Vijverberg, S. J., Sont, J. K., Scichilone, N., Bieksiene, K., Ten Brinke, A., Csoma, Z., Dahlén, B., Gemicioglu, B., Grisle, I., Kuna, P., Lazic, Z., Mihaltan, F., Popović-Grle, S., Škrgat, S., Marcon, A., & 4 othersCaminati, M., Djukanovic, R., Porsbjerg, C. & Maitland Van Der Zee, A-H., Jul 2023, In: ERJ open research. 9, 3

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Identifying risk factors for COPD and adult-onset asthma: an umbrella review

    P4O2 consortium, 30 Jun 2023, In: European respiratory review. 32, 168, 230009.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19

    Baalbaki, N., Duijvelaar, E., Said, M. M., Schippers, J., Bet, P. M., Twisk, J., Fritchley, S., Longo, C., Mahmoud, K., Maitland-van der Zee, A. H., Bogaard, H. J., Swart, E. L., Aman, J. & Bartelink, I. H., 1 May 2023, In: European journal of pharmaceutical sciences. 184, 106418.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

    COMSA working group in the 3TR consortium, 1 Apr 2023, In: European respiratory journal. 61, 4, 2200606.

    Research output: Contribution to journalReview articleAcademicpeer-review

  6. Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma

    Martin-Almeida, M., Perez-Garcia, J., Herrera-Luis, E., Rosa-Baez, C., Gorenjak, M., Neerincx, A. H., Sardón-Prado, O., Toncheva, A. A., Harner, S., Wolff, C., Brandstetter, S., Valletta, E., Abdel-Aziz, M. I., Hashimoto, S., Berce, V., Corcuera-Elosegui, P., Korta-Murua, J., Buntrock-Döpke, H., Vijverberg, S. J. H., Verster, J. C., & 10 othersKerssemakers, N., Hedman, A. M., Almqvist, C., Villar, J., Kraneveld, A. D., Potočnik, U., Kabesch, M., Zee, A. H. M. D., on behalf of the SysPharmPediA consortium & Pino-Yanes, M., 1 Mar 2023, In: Biomedicines. 11, 3, 676.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Validation of volatile metabolites of pulmonary oxidative injury: a bench to bedside study

    DARTS consortium, 1 Mar 2023, In: ERJ open research. 9, 2, 00427-2022.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. A Systematic Review of Chest Imaging Findings in Long COVID Patients

    on behalf of the P4O2 Consortium, 1 Feb 2023, In: Journal of Personalized Medicine. 13, 2, 282.

    Research output: Contribution to journalReview articleAcademicpeer-review

  9. Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate-to-severe asthma

    the SysPharmPediA Consortium, 1 Feb 2023, In: Pediatric allergy and immunology. 34, 2, e13919.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study

    on behalf of the SysPharmPediA consortium, 1 Feb 2023, In: European journal of pharmaceutical sciences. 181, 106360.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...34 Next

ID: 71855